Cold winter weather can affect your patients’ physical health, and one chilly issue to keep on your radar is the effect of ...

Miners and financial stocks, along with defence stocks, were the biggest drivers of the FTSE 100's gains this year.

AstraZeneca said on Monday that a late‑stage trial testing its blockbuster therapy Imfinzi in combination with its ...

An update from AstraZeneca ( (GB:AZN)) is now available. AstraZeneca has disclosed an internal share transfer involving Non-Executive Director and PDMR Philip Broadley, who gifted 5,735 ordinary ...

AstraZeneca offers a rare, secular growth profile in biopharma, underpinned by a diversified commercial asset base and layered patent expirations. AZN faces a minor patent cliff, with most key ...

The pharmaceutical company said its ceralasertib combination didn’t meet the primary goal of a late-stage clinical trial for ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, a preclinical ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating update from JPMorgan on December 8, with the firm lifting the price target on ...

At Ford Field on Thursday, Amon-Ra St. Brown and the Detroit Lions (7-5) face Javonte Williams and the Dallas Cowboys (6-5-1) in a matchup featuring two of the brightest stars in the NFL, beginning at ...

The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, after getting approval from the city of Frederick’s Planning Commission. The ...

AstraZeneca’s LATIFY phase 3 trial evaluating ceralasertib in combination with Imfinzi did not meet its primary endpoint of overall survival in ...

A quick look at the attainability of getting the top 10 toughest words. No reason to dillydally. By Eve Washington The reporter reviewed millions of data records, a process that doubled as an ...